Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hematologic Malignancies
Neurology
Questions discussed in this category
How do you manage IgM related peripheral neuropathy?
Do you utilize rituximab or any other specific management strategies?
2 Answers available
How would you approach grade 2 neurologic toxicity in a patient on daratumumab, dexamethasone, and lenalidomide for relapsed multiple myeloma?
Regimen currently 25 mg lenalidomide D1-21 of D28 day cycles, Daratumumab 16 mg/kg every 2 weeks.
1 Answer available
When patients develop headaches from luspatercept, do they tend to improve over time?
1 Answer available
Do you typically see peripheral neuropathy in patients with castleman syndrome?
2 Answers available
Do you recommend work up for POEMS and/or amyloidosis for IgM monoclonal gammopathies associated with neuropathy?
Can you expand on this by sharing exactly what this routine workup should include? What additional tests outside of evaluating for POEMS and amyloidos...
2 Answers available
17010
15839
15316
15147
10962
Papers discussed in this category
Mayo Clin Proc,
Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
Neurol Sci, 2021 Sep 16
Paraproteinemia and neuropathy.
Pediatr Blood Cancer, 2021 Oct
Idiopathic multicentric Castleman disease with TAFRO clinical subtype responsive to IL-6/JAK inhibition: A pediatric case series.
Related Topics in Hematologic Malignancies
Breast Cancer
Head and Neck Cancers
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers
Pediatric Oncology
Sarcoma